342MO Metastatic hormone receptor-positive breast cancer outcomes in 628 patients with BRCA1, BRCA2, or PALB2 pathogenic variants: Real-world data analysis of genomics and targeted therapy sequencing
Year: 2024
Type: article
Source: Annals of Oncology
Authors: G. Parkinson, M. Lustberg, S. Nazari, A. Elliott, G. Sledge, R. Jeselsohn, E. Hsu, R.W. Sobol, A. Sandoval-Leon, R. Gopalakrishnan, I. Makhoul, L.E. Nye, A. Kurian, F. Lynce, S. Graff
Institutions: Rhode Island Hospital, Lifespan, Yale University, Caris Life Sciences (United States), Dana-Farber Cancer Institute, Brown University, Baptist Hospital of Miami, Baptist Health South Florida, Mount Sinai Medical Center, Central Arkansas Radiation Therapy Institute, University of Kansas Medical Center, Stanford Medicine, Stanford University
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4402561605